Evidence map›Paper›PMID 32440921›Full record

ArticleJournal of neurology2020

Pick's disease: clinicopathologic characterization of 21 cases.

Parichita Choudhury, Eugene L Scharf, Michael A Paolini, Jonathan Graff-Radford, Eva C Alden, Mary M Machulda, David T Jones, Julie A Fields, Melissa E Murray, Neill R Graff-Radford and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of neurology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 38 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Tauopathies: new perspectives and challenges.Molecular neurodegeneration · 2022
    Review
  9. Article
  10. Clinical Spectrum of Tauopathies.Frontiers in neurology · 2022
    Review
  11. Review
  12. Neuroimaging in Frontotemporal Dementia: Heterogeneity and Relationships with Underlying Neuropathology.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2021
    Review
  13. Clinical and neuropathological associations of plasma AβAlzheimer's & dementia (Amsterdam, Netherlands)
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors at 3 institutions in 1 country.

Parichita ChoudhuryDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.ORCID http://orcid.org/0000-0002-8750-1160
Eugene L ScharfDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Michael A PaoliniDepartment of Molecular and Cellular Medicine, Texas A&M, College Station, TX, USA.
Jonathan Graff-RadfordDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Eva C AldenDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Mary M MachuldaDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
David T JonesDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Julie A FieldsDepartment of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.
Melissa E MurrayDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Neill R Graff-RadfordDepartment of Neurology, Mayo Clinic, Jacksonville, FL, USA.
Eleni ConstantopoulosDepartment of Laboratory Medicine and Pathology (Neuropathology), Mayo Clinic, Rochester, MN, USA.
Ross R ReichardDepartment of Laboratory Medicine and Pathology (Neuropathology), Mayo Clinic, Rochester, MN, USA.
David S KnopmanDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Joseph R DuffyDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Dennis W DicksonDepartment of Neuroscience, Mayo Clinic, Jacksonville, FL, USA.
Joseph E ParisiDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Keith A JosephsDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Ronald C PetersenDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA.
Bradley F BoeveDepartment of Neurology, Mayo Clinic, 200 1st St SW, Rochester, MN, 55905, USA. bboeve@mayo.edu.
Mayo Clinic · USMayo Clinic in Florida · USWinnMed · US

Funding

Alzheimer Disease Research Center, Mayo Clinic P50 AG062677Alzheimer's Disease Research Center, Mayo Clinic P30 AG016574
6 · The paper itself

Abstract

backgroundPick's disease (PiD) is a unique subtype of frontotemporal lobar degeneration characterized pathologically by aggregates of 3-Repeat tau. Few studies have examined the clinical variability and disease progression in PiD. We describe the clinical features, neuropsychological profiles and coexistent pathologies in 21 cases of autopsy-confirmed PiD.

methodsThis study was a retrospective analysis of patients with Pick's disease evaluated at Mayo Clinic, Rochester or Jacksonville (1995-2018), and identified through an existing database.

resultsTwenty-one cases with sufficient clinical data were identified. Behavioral variant FTD (bvFTD; 12/21) was the most common phenotype, followed by primary progressive aphasia (PPA; 7/21), corticobasal syndrome (CBS; 1/21) and amnestic dementia (1/21). Median age at disease onset was 54 years, with PPA cases (median = 52 years) presenting earlier than bvFTD (median = 59). Median disease duration (onset-death) overall was 10 years and did not differ significantly between bvFTD (median = 9.5 years) and PPA (median = 13). Age at death was not significantly different in PPA (median = 66) compared to bvFTD (median = 68.5). A third of the cases (n = 7/21) demonstrated pure PiD pathology, while the remainder showed co-existent other pathologies including Alzheimer's type (n = 6), cerebral amyloid angiopathy (n = 3), combined Alzheimer's and amyloid angiopathy (n = 4), and Lewy body disease (n = 1).

conclusionsOur study shows that bvFTD and PPA are the most common clinical phenotypes associated with PiD, although rare presentations such as CBS were also seen. Coexisting non-Pick's pathology was also present in many cases. Our study highlights the clinical and pathologic heterogeneity in PiD.

Indexed as

Aphasia, Primary ProgressiveFrontotemporal DementiaFrontotemporal Lobar DegenerationPick Disease of the BrainHumansRetrospective StudiesFrontotemporal dementiaPick’s diseasePrimary progressive aphasia

Identifiers

PMID32440921
OpenAlexW3026038412

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.